Get the Stockscreener App
19.62
3.32%
0.63
After Hours:
19.24
-0.38
-1.94%
Sanara Medtech Inc stock is traded at $19.62, with a volume of 29,998.
It is up +3.32% in the last 24 hours and up +13.81% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
See More
Previous Close:
$18.99
Open:
$19
24h Volume:
29,998
Relative Volume:
0.49
Market Cap:
$179.81M
Revenue:
$103.14M
Net Income/Loss:
$-5.82M
P/E Ratio:
-4.5077
EPS:
-4.3526
Net Cash Flow:
$2.14M
1W Performance:
+4.92%
1M Performance:
+13.81%
6M Performance:
-28.91%
1Y Performance:
-39.37%
1-Day Range:
$18.92
$20.05
1-Week Range:
$17.85
$20.05
52-Week Range:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
19.62 | 174.04M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Lake Street | Buy |
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
2,804 SMTI restricted shares granted to controller Ashley Mackey - Stock Titan
How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target - Yahoo Finance
Precision Trading with Sanara Medtech Inc. (SMTI) Risk Zones - Stock Traders Daily
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - The Globe and Mail
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - PR Newswire
Sanara MedTech shares rise more than 3% despite fourth-quarter earnings miss - MSN
SMTI Sanara MedTech climbs 2.5 percent in daily trading despite Q4 2025 EPS landing below analyst estimates.Recovery Report - Newser
SMTI Sanara MedTech reports Q4 2025 lower than expected EPS, posts minor share gain despite earnings miss.Growth Pick - Newser
Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach - MSN
Sanara MedTech expects Q4 revenue between $27.2M and $27.7M - MSN
Technical Reactions to SMTI Trends in Macro Strategies - Stock Traders Daily
What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity? - Insider Monkey
Sanara MedTech Inc. to Report First Quarter 2026 Financial Resul - GuruFocus
Sanara MedTech Inc stock (US80007P1057): Is its wound care innovation model strong enough to scale f - AD HOC NEWS
Sanara MedTech (SMTI) Stock Swing Trade (Bullish Sentiment) 2026-04-20Investment Community Signals - Cổng thông tin điện tử tỉnh Lào Cai
How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions - Yahoo Finance
Sanara MedTech Inc stock (US80007P1057): Is its wound care niche strong enough to drive investor ups - AD HOC NEWS
[ARS] Sanara MedTech Inc. SEC Filing - Stock Titan
Nine-director slate, pay votes at Sanara MedTech (SMTI) 2026 online meeting - Stock Titan
Sanara MedTech (SMTI) COO reports tax withholding on vested restricted stock - Stock Titan
SMTI: Lake Street Initiates Buy Rating on Sanara MedTech - Meyka
SMTI Initiates Coverage On Lake Street -- Rating Set to Buy - GuruFocus
Sanara MedTech (NASDAQ:SMTI) Coverage Initiated by Analysts at Lake Street Capital - MarketBeat
Baird entities report 21,075 shares in Sanara MedTech (SMTI) Schedule 13G/A - Stock Titan
Sanara MedTech to Report Q1 2026 Earnings on May 12 - National Today
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 - The Manila Times
Sanara MedTech sets May 12 webcast for first-quarter 2026 results - Stock Titan
Sanara MedTech Faces Securities Fraud Probe After Tissue Health Plus Shutdown - National Today
Aug Analyst Calls: Does Sanara MedTech Inc have pricing power2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
EV Market: Can Sanara MedTech Inc grow without external funding2026 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn
Inflation Data: Whats next for Sanara MedTech Inc stock2026 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Sanara MedTech Investigated for Potential Securities Fraud - National Today
Sanara MedTech, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Volume Recap: How does Sanara MedTech Inc correlate with Nasdaq2026 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (SMTI) Edition - Stock Traders Daily
Chart Watch: Is Sanara MedTech Inc stock a top performer YTDSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
Tech Rally: Is Sanara MedTech Inc vulnerable to short sellers2026 Stock Rankings & Consistent Growth Equity Picks - baoquankhu1.vn
Is Sanara MedTech (SMTI) Stock suitable for dividend investors | Price at $17.14, Up 1.84%Shared Trade Alerts - Newser
Q1 EPS Estimates for Sanara MedTech Lowered by HC Wainwright - Defense World
SMTI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can Sanara MedTech (SMTI) Stock Rebound in 2026 | Price at $16.83, Down 2.09%Early Entry - Newser
Momentum Shift: Can Sanara MedTech Inc grow without external fundingRecession Risk & Smart Money Movement Alerts - baoquankhu1.vn
H.C. Wainwright reiterates Sanara MedTech stock rating at buy By Investing.com - Investing.com Canada
Sanara MedTech (NASDAQ:SMTI) Lowered to Hold Rating by Wall Street Zen - Defense World
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI) - Defense World
Q4 EPS Estimates for Sanara MedTech Decreased by Analyst - MarketBeat
Recap Report: Is Sanara MedTech Inc undervalued by DCF analysis2026 Top Decliners & Stepwise Swing Trade Plans - baoquankhu1.vn
H.C. Wainwright Maintains Sanara MedTech(SMTI.US) With Buy Rating, Maintains Target Price $36 - Moomoo
Aug Chart Watch: Is Sanara MedTech Inc showing insider buying2026 Technicals & Reliable Entry Point Alerts - baoquankhu1.vn
(SMTI) Volatility Zones as Tactical Triggers - Stock Traders Daily
Sanara MedTech Q4 2025 Earnings Call Transcript - MarketBeat
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):